• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 5. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Recent Advances in the Study of Methyl 4-(methylamino)sulfonylbenzoate (CAS: 474398-77-1) in Chemical Biology and Pharmaceutical Research

Methyl 4-(methylamino)sulfonylbenzoate (CAS: 474398-77-1) is a sulfonamide derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its unique sulfonyl and ester functional groups, has been explored for its role in drug discovery, enzyme inhibition, and as a building block in the synthesis of more complex molecules. Recent studies have highlighted its versatility and efficacy in various biological contexts, making it a compound of interest for researchers aiming to develop novel therapeutic agents.

One of the key areas of research involving Methyl 4-(methylamino)sulfonylbenzoate is its potential as an enzyme inhibitor. Sulfonamide derivatives are well-known for their ability to interact with enzymes, particularly carbonic anhydrases, which play crucial roles in physiological processes such as pH regulation and CO2 transport. Recent studies have demonstrated that Methyl 4-(methylamino)sulfonylbenzoate exhibits inhibitory activity against specific isoforms of carbonic anhydrase, suggesting its potential use in treating conditions like glaucoma, epilepsy, and certain cancers. The compound's mechanism of action involves binding to the active site of the enzyme, thereby disrupting its catalytic activity.

In addition to its enzyme inhibitory properties, Methyl 4-(methylamino)sulfonylbenzoate has been investigated for its role in drug synthesis. Its structural features make it a valuable intermediate in the preparation of more complex sulfonamide-based drugs. For instance, recent synthetic studies have utilized this compound as a precursor in the development of novel antimicrobial and anti-inflammatory agents. The ester group in Methyl 4-(methylamino)sulfonylbenzoate allows for further functionalization, enabling researchers to tailor the compound's properties to specific therapeutic needs. This adaptability underscores its importance in medicinal chemistry.

Another promising avenue of research involves the use of Methyl 4-(methylamino)sulfonylbenzoate in targeted drug delivery systems. Recent advancements in nanotechnology have explored the incorporation of sulfonamide derivatives into drug carriers to enhance specificity and reduce off-target effects. Preliminary studies have shown that Methyl 4-(methylamino)sulfonylbenzoate can be conjugated to nanoparticles, improving their ability to deliver drugs to specific tissues or cells. This approach holds great promise for the treatment of diseases that require precise targeting, such as cancer and neurodegenerative disorders.

Despite these advancements, challenges remain in the widespread application of Methyl 4-(methylamino)sulfonylbenzoate. Issues such as solubility, bioavailability, and potential toxicity need to be addressed through further research. Recent studies have begun to explore modifications to the compound's structure to overcome these limitations, with promising results. For example, the introduction of hydrophilic groups has been shown to improve solubility without compromising its biological activity. These efforts highlight the ongoing need for innovative solutions to optimize the compound's performance in therapeutic settings.

In conclusion, Methyl 4-(methylamino)sulfonylbenzoate (CAS: 474398-77-1) represents a versatile and promising compound in the field of chemical biology and pharmaceutical research. Its applications in enzyme inhibition, drug synthesis, and targeted drug delivery demonstrate its potential to contribute to the development of novel therapeutic agents. However, further studies are required to address existing challenges and fully realize its therapeutic potential. As research in this area continues to evolve, Methyl 4-(methylamino)sulfonylbenzoate is likely to remain a focal point for scientists seeking to advance the frontiers of medicine.

• 10252-63-8(4-(Methylamino)sulfonylbenzoic acid)
• 1094752-93-8(methyl 3-(methylsulfamoyl)benzoate)
• 83112-39-4(Benzoic acid, 3-[(diMethylaMino)sulfonyl]-, ethyl ester)
• 471925-05-0(Benzoic acid, 4-[[(phenylsulfonyl)amino]methyl]-, methyl ester)
• 35623-11-1(3-(Methylamino)sulphonylbenzoic Acid)
• 83112-37-2
• 874841-20-0(ethyl 4-(methylsulfamoyl)benzoate)
• 22808-73-7(Methyl 4-Sulfamoylbenzoate)
• 158038-67-6(Methyl 4-(4-Methylbenzenesulfonamido)benzoate)
• 107920-79-6(Methyl 4-benzenesulfonamidobenzoate)